Rheumatology Network's Top 5: August 6, 2022

Published on: 

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending August 6, 2022.

FDA Approves Ustekinumab for Pediatric Patients with Psoriatic Arthritis

Patients with pediatric psoriatic arthritis will now have access to the first-in-class treatment option, ustekinumab.

Updated Vaccination Guidance for Patients with Rheumatic and Musculoskeletal Diseases

The American College of Rheumatology announced updated vaccination guidance for patients with rheumatic diseases, including expanding indications for certain vaccines for those receiving immunosuppressive medications, medication management, and vaccination delay.

How can Rheumatologists Prevent and Manage Burnout?

Whether it is leaning on the support of colleagues, mindfulness meditation, or jujitsu, rheumatologists weigh on how they personally prevent and manage symptoms of burnout.

What are the Current Challenges Contributing to Physician Burnout in Rheumatologists?

Besides the obvious stressors regarding the uncertainty of COVID-19 and implementation of telemedicine, other issues include the rheumatologist shortage, referred to as the “great resignation."

Rheumatoid Arthritis Quiz: Disease Activity Score

Assessing disease activity is an important part of a treat-to-target strategy. How much do you know about the different approaches? Take this quiz to find out.